Wen PY, Huse JT. 2016 World Health Organization Classification of Central Nervous System Tumors. Continuum (Minneap Minn). 2017;23(6, Neuro-oncology):1531–47.

PubMed  Google Scholar 

Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, et al. The epidemiology of glioma in adults: a “state of the science” review. Neuro Oncol. 2014;16(7):896–913.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hadjipanayis CG, Van Meir EG. Tumor initiating cells in malignant gliomas: biology and implications for therapy. J Mol Med (Berl). 2009;87(4):363–74.

Article  PubMed  Google Scholar 

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berger TR, Wen PY, Lang-Orsini M, Chukwueke UN. World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review. JAMA Oncol. 2022;8(10):1493–501.

Article  PubMed  Google Scholar 

Rong L, Li N, Zhang ZZ. Emerging therapies for glioblastoma: current state and future directions. J Exp Clin Cancer Res. 2022;41(1):142.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tran B, Rosenthal MA. Survival comparison between glioblastoma multiforme and other incurable cancers. J Clin Neurosci. 2010;17(4):417–21.

Article  CAS  PubMed  Google Scholar 

Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015. Neuro Oncol. 2018;20(suppl_4):iv1–86.

Article  PubMed  PubMed Central  Google Scholar 

Grivennikov SI, Greten FR, Karin M. Immunity, Inflammation, and Cancer. Cell. 2010;140(6):883–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yasumatsu R, Wakasaki T, Hashimoto K, Nakashima K, Manako T, Taura M, Matsuo M, Nakagawa T. Monitoring the neutrophil-to-lymphocyte ratio may be useful for predicting the anticancer effect of nivolumab in recurrent or metastatic head and neck cancer. Head Neck. 2019;41(8):2610–8.

Article  PubMed  Google Scholar 

Matsuda A, Yamada T, Matsumoto S, Shinji S, Ohta R, Sonoda H, Shinozuka E, Sekiguchi K, Suzuki H, Yoshida H. Prognostic Role of the Platelet-to-Lymphocyte Ratio for Patients With Metastatic Colorectal Cancer Treated With Aflibercept. In Vivo. 2020;34(5):2667–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Q, Pu Y, Gong Z, Yu Y, Sun W, Cheng Z, Wang W, Zhao J. Preoperative systemic immune-inflammation index for predicting the prognosis of thymoma with radical resection. Thorac Cancer. 2023;14(13):1192–200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bruni D, Angell HK, Galon J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer. 2020;20(11):662–80.

Article  CAS  PubMed  Google Scholar 

Bispo RG, Bastos Siqueira IF, de Oliveira BFS, Moreira Fernandes CE, Figueiredo LA, Cintra LP, de Oliveira AJM. Prognostic Value of the Platelet-lymphocyte Ratio for Glioblastoma: A Systematic Review. World Neurosurg. 2023;175:137-141.e131.

Article  PubMed  Google Scholar 

Gomes Dos Santos A, de Carvalho RF, de Morais A, Silva TM, Baylão VMR, Azevedo M, de Oliveira AJM. Role of neutrophil-lymphocyte ratio as a predictive factor of glioma tumor grade: A systematic review. Crit Rev Oncol Hematol. 2021;163:103372.

Article  PubMed  Google Scholar 

Nakamoto S, Ikeda M, Kubo S, Yamamoto M, Yamashita T, Kuwahara C. Prognostic Value of Lymphocyte-to-Monocyte Ratio for Japanese Patients With Differentiated Thyroid Cancer Treated With Sorafenib Therapy. Cancer Diagn Progn. 2021;1(5):491–8.

Article  PubMed  PubMed Central  Google Scholar 

Zapała Ł, Kunc M, Sharma S, Biernat W, Radziszewski P. Low Lymphocyte-to-Monocyte Ratio Is the Potential Indicator of Worse Overall Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus. Diagnostics (Basel, Switzerland). 2021;11(11):2159.

PubMed  PubMed Central  Google Scholar 

Lang C, Egger F, Alireza Hoda M, Saeed Querner A, Ferencz B, Lungu V, Szegedi R, Bogyo L, Torok K, Oberndorfer F, et al. Lymphocyte-to-monocyte ratio is an independent prognostic factor in surgically treated small cell lung cancer: An international multicenter analysis. Lung cancer (Amsterdam, Netherlands). 2022;169:40–6.

Article  CAS  PubMed  Google Scholar 

Hu Q, Shen G, Li Y, Xie Y, Ma X, Jiang L, Lv Q. Lymphocyte-to-monocyte ratio after primary surgery is an independent prognostic factor for patients with epithelial ovarian cancer: A propensity score matching analysis. Front Oncol. 2023;13:1139929.

Article  PubMed  PubMed Central  Google Scholar 

Lv M, Wang K, Zhang Z, Zhang Z, Wan J. The predictive value of lymphocyte to monocyte ratio for overall survival in cholangiocarcinoma patients with hepatic resection. Cancer Med. 2023;12(8):9482–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou XW, Dong H, Yang Y, Luo JW, Wang X, Liu YH, Mao Q. Significance of the prognostic nutritional index in patients with glioblastoma: A retrospective study. Clin Neurol Neurosurg. 2016;151:86–91.

Article  PubMed  Google Scholar 

Wang PF, Song HW, Cai HQ, Kong LW, Yao K, Jiang T, Li SW, Yan CX. Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival. Oncotarget. 2017;8(30):50117–23.

Article  PubMed  PubMed Central  Google Scholar 

Bao Y, Yang M, Jin C, Hou S, Shi B, Shi J, Lin N. Preoperative Hematologic Inflammatory Markers as Prognostic Factors in Patients with Glioma. World Neurosurg. 2018;119:e710–6.

Article  PubMed  Google Scholar 

He ZQ, Duan H, Lin FH, Zhang J, Chen YS, Zhang GH, Guo CC, Ke C, Zhang XH, Chen ZH, et al. Pretreatment neutrophil-to-lymphocyte ratio plus albumin-to-gamma-glutamyl transferase ratio predict the diagnosis of grade III glioma. Ann Transl Med. 2019;7(22):623.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang ZY, Zhan YB, Zhang FJ, Yu B, Ji YC, Zhou JQ, Bai YH, Wang YM, Wang L, Jing Y, et al. Prognostic value of preoperative hematological markers combined with molecular pathology in patients with diffuse gliomas. Aging. 2019;11(16):6252–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chim ST, Sanfilippo P, O’Brien TJ, Drummond KJ, Monif M. Pretreatment neutrophil-to-lymphocyte/monocyte-to-lymphocyte ratio as prognostic biomarkers in glioma patients. J Neuroimmunol. 2021;361: 577754.

Article  CAS  PubMed  Google Scholar 

He Q, Li L, Ren Q. The Prognostic Value of Preoperative Systemic Inflammatory Response Index (SIRI) in Patients With High-Grade Glioma and the Establishment of a Nomogram. Front Oncol. 2021;11: 671811.

Article  PubMed  PubMed Central  Google Scholar 

Madhugiri VS, Subeikshanan V, Dutt A, Moiyadi A, Epari S, Shetty P, Gupta T, Jalali R, Dutt AK. Biomarkers of Systemic Inflammation in Patients with Glioblastoma: An Analysis of Correlation with Tumour-Related Factors and Survival. Neurol India. 2021;69(4):894–901.

Article  PubMed  Google Scholar 

Xie T, Guo X, Duan H, He Z, Mou Y. Prognostic value of modified systemic inflammatory score in patients with newly diagnosed high-grade gliomas. Clin Neurol Neurosurg. 2021;201: 106428.

Article  PubMed  Google Scholar 

Yan P, Li JW, Mo LG, Huang QR. A nomogram combining inflammatory markers and clinical factors predicts survival in patients with diffuse glioma. Medicine (Baltimore). 2021;100(47): e27972.

Article  CAS  PubMed  Google Scholar 

Chen XY, Pan DL, Xu JH, Chen Y, Xu WF, Chen JY, Wu ZY, Lin YX, You HH, Ding CY, et al. Serum Inflammatory Biomarkers Contribute to the Prognosis Prediction in High-Grade Glioma. Front Oncol. 2022;11:754920.

Qi Z, Cai J, Meng X, Cai S, Tang C, Lang L. Prognostic value of preoperative inflammatory markers among different molecular subtypes of lower-grade glioma. J Clin Neurosci. 2022;96:180–6.

Article  CAS  PubMed  Google Scholar 

Shi X, Li H, Xu Y, Nyalali AMK, Li F. The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients. Neurol Sci. 2022;43(9):5523–31.

Article  PubMed  PubMed Central  Google Scholar 

Stoyanov GS, Lyutfi E, Georgieva R, Dzhenkov DL, Petkova L, Ivanov BD, Kaprelyan A, Ghenev P. The Role of Preoperative Neutrophil, Platelet, and Monocyte to Lymphocyte Ratios as Independent Prognostic Factors for Patient Survival in WHO 2021 Glioblastoma: A Single-Center Retrospective Study. Cureus. 2022;14(6): e25801.

PubMed  PubMed Central  Google Scholar 

Yang C, Lan T, Wang Y, Huang WH, Li SM, Li J, Li FP, Li YR, Wang ZF, Li ZQ. Cumulative Scoring Systems and Nomograms for Predicating Survival in Patients With Glioblastomas: A Study Based on Peripheral Inflammatory Markers. Front Oncol. 2022;12: 716295.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duan X, Yang B, Zhao C, Tie B, Cao L, Gao Y. Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model. BMC Cancer. 2023;23(1)